Abstract:Our approach for the comprehensive analysis of the expression profiles of several microRNAs identified microRNA‐188‐5p to be independently associated with the prognosis of renal cell carcinoma (RCC). MicroRNA‐188‐5p is a potent suppressor of myristoylated alanine‐rich C‐kinase substrate (MARCKS). MicroRNA‐188‐5p‐mediated downregulation of MARCKS significantly inhibits the AKT/mTOR signaling pathway and suppresses RCC xenograft tumor progression. MicroRNA ‐188‐5p could be a valuable new molecule for RCC diagnosis and prognosis. Many current microRNA (miRNA) expression datasets for renal cell carcinoma (RCC) often show inconsistent analysis results, so a shift to comprehensive analysis of multiple datasets can effectively accelerate molecular screening for precision medicine and translational medicine research. MicroRNA (miR)‐188‐5p is a clinically noteworthy miRNA whose aberrant expression was previously observed in a variety of cancers, but its role in RCC is unclear. In this study, we undertook a comprehensive analysis of four RCC miRNA expression datasets and validated the results using The Cancer Genome Atlas (TCGA) dataset and a cohort of collected clinical samples. Fifteen miRNAs were identified as potential diagnostic markers by the analysis of four RCC miRNAs datasets. Analysis of the TCGA kidney renal clear cell carcinoma dataset showed significantly shorter survival in RCC patients with reduced miR‐188‐5p expression levels, and our collection of RCC clinical samples showed low miR‐188‐5p expression in the tumors. Overexpression of miR‐188‐5p in Caki‐1 and 786‐O cells inhibited cell growth, colony formation, invasion, and migration. In contrast, miR‐188‐5p inhibitors reversed these cell phenotypes. We identified a binding site for miR‐188‐5p in the 3′‐UTR region of myristoylated alanine‐rich C‐kinase substrate (MARCKS) mRNA and demonstrated an interaction between these two molecules. Quantitative RT‐PCR and western blot analysis revealed that miR‐188‐5p could regulate the AKT/mTOR signaling pathway through MARCKS. Mouse transplantation tumor assay indicated that miR‐188‐5p reduced the tumorigenicity of RCC in vivo. MicroRNA‐188‐5p could be a valuable new molecule for RCC diagnosis and prognosis.

MiR-30d Induces Apoptosis and is Regulated by the Akt/FOXO Pathway in Renal Cell Carcinoma

Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway

Identification of Mir-30B As an Oncogene in Renal Cell Carcinoma

circFOXO3 Induced by KLF16 Modulates Clear Cell Renal Cell Carcinoma Growth and Natural Killer Cell Cytotoxic Activity through Sponging miR-29a-3p and miR-122-5p

MicroRNA-381-3p Functions as a Dual Suppressor of Apoptosis and Necroptosis and Promotes Proliferation of Renal Cancer Cells

Molecular and Cellular Pathobiology FoxO Transcription Factors Promote AKT Ser 473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI 3 K – AKT Pathway

Mir-30A-5p in the Tumorigenesis of Renal Cell Carcinoma: A Tumor Suppressive Microrna

MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression

MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)

Data from FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K–AKT Pathway

MicroRNA-183 Promotes the Proliferation and Metastasis of Renal Cell Carcinoma Through Targeting Dickkopf-related Protein 3

Integrated analysis identifies microRNA‐188‐5p as a suppressor of AKT/mTOR pathway in renal cancer

MicroRNA-142-3p promotes renal cell carcinoma progression by targeting RhoBTB3 to regulate HIF-1 signaling and GGT/GSH pathways

Decreased Mir-200A-3p is a Key Regulator of Renal Carcinoma Growth and Migration by Directly Targeting CBL.

MicroRNA-509-3p Inhibits Cancer Cell Proliferation and Migration by Targeting the Mitogen-Activated Protein Kinase Kinase Kinase 8 Oncogene in Renal Cell Carcinoma

Oncogenic Microrna-142-3p is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma.

MicroRNA-451a is Associated with Cell Proliferation, Migration and Apoptosis in Renal Cell Carcinoma

Mir-362-3p Targets Nemo-Like Kinase and Functions As a Tumor Suppressor in Renal Cancer Cells

Downregulation of Transmembrane Protein 40 by Mir-138-5p Suppresses Cell Proliferation and Mobility in Clear Cell Renal Cell Carcinoma.

Mir-30B-5p Up-Regulation Related to the Dismal Prognosis for Patients with Renal Cell Cancer.

Mir-134 Functions As A Tumor Suppressor In Cell Proliferation And Epithelial-To-Mesenchymal Transition By Targeting Kras In Renal Cell Carcinoma Cells